Dongxu Shu

4 Patents

• US125827182026

  Integrin Targeting Ligands and Uses Thereof

  Arrowhead Pharmaceuticals, Inc.

  0 cites
• US125347262026

  Composition and Method for Inhibiting Angiotensinogen (AGT) Protein Expression

  Shanghai Argo Biopharmaceutical Co., Ltd.

  0 cites
• US122216102025

  Rnai Agents for Inhibiting Expression of HIF-2 Alpha ( EPAS1 ), Compositions Thereof, and Methods of Use

  Arrowhead Pharmaceuticals, Inc.

  0 cites
• US115977012023

  Integrin Ligands and Uses Thereof

  Arrowhead Pharmaceuticals, Inc.

  0 cites